Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.95 USD | +1.27% | +0.17% | +11.81% |
Business Summary
Number of employees: 117
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
GSK - Royalty
100.0
%
| 5 | 51.4 % | 17 | 100.0 % | +224.51% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States and Australia
100.0
%
| 10 | 100.0 % | 17 | 100.0 % | +66.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Faga
CEO | Chief Executive Officer | 44 | 21-11-25 |
Dennis Mulroy
DFI | Director of Finance/CFO | 69 | 20-07-14 |
Paul Lizzul
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-07-30 |
Nick Montemarano
IRC | Investor Relations Contact | - | - |
Priya Raina
PRN | Corporate Officer/Principal | - | 22-06-30 |
Ben Stone
PRN | Corporate Officer/Principal | - | 21-12-31 |
Martin Dahl
PRN | Corporate Officer/Principal | - | 17-12-31 |
Beth Mueller
HRO | Human Resources Officer | - | 19-09-30 |
David McKeon
AUD | Comptroller/Controller/Auditor | 52 | 17-03-31 |
Lewis Gryziewicz
LAW | General Counsel | - | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hollings Renton
BRD | Director/Board Member | 77 | 15-06-29 |
Dennis Fenton
BRD | Director/Board Member | 72 | 18-03-04 |
Magda Marquet
BRD | Director/Board Member | 65 | 21-01-17 |
Oleg Nodelman
BRD | Director/Board Member | 47 | 21-04-07 |
John Schmid
BRD | Director/Board Member | 61 | 15-06-29 |
John Orwin
CHM | Chairman | 59 | 23-09-14 |
J. Ware
BRD | Director/Board Member | 71 | 17-08-23 |
Daniel Faga
CEO | Chief Executive Officer | 44 | 21-11-25 |
Rita Jain
BRD | Director/Board Member | 62 | 23-04-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,318,644 | 26,799,162 ( 98.10 %) | 0 | 98.10 % |
Company contact information
AnaptysBio, Inc.
10770 Wateridge Circle Suite 210
92121-5801, San Diego
+858 362 6295
http://www.anaptysbio.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.81% | 654M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ANAB Stock
- Company AnaptysBio, Inc.